Latest news with #AlamedaHealthcare
Zawya
18-07-2025
- Business
- Zawya
UK-headquartered Addleshaw Goddard advises on $190mln investment in Egypt's Alameda
Cairo – International law firm Addleshaw Goddard, which is headquartered in London, has advised Egyptian private group Alameda Healthcare on its $190 million minority investment agreement with London-based private equity firm Development Partners International (DPI) and its co-investors. The transaction is structured primarily as a capital increase and is expected to close in the third quarter (Q3) of 2025, subject to customary regulatory approvals, according to a press release. The proceeds from the investment will be used to scale Alameda's hospital and outpatient network while investing in cutting-edge clinical technologies. In addition, the funding will be used to expand the healthcare group's centers of excellence in specialized medical fields such as cardiology, oncology, and liver disease. The proceeds will also support talent development initiatives aimed at retaining and upskilling Egyptian medical professionals and reversing brain drain from the sector. Meanwhile, the transaction further reinforces Addleshaw Goddard's position throughout the Middle East and Africa. The deal marks the largest private equity investment of its kind in Egypt's healthcare sector to date and represents a major milestone for both Alameda and DPI. It is worth mentioning that EFG Hermes acted as the sole M&A financial advisor on the signing of binding agreements for Alameda's deal with DPI. The transaction also enables Alameda to accelerate its strategic expansion across Egypt and into Gulf markets, further advancing its ambition to position Egypt as a regional hub for world-class healthcare. Partner and Head of Investment Management and Funds at Addleshaw Goddard MENA, Philip Dowsett, said: 'DPI's investment reflects growing global confidence in Egypt's healthcare infrastructure and Alameda's leadership position within it.' Dowsett noted: 'This deal also demonstrates our ability to advise on transformative cross-border investments that deliver regional impact.' Earlier in 2025, the healthcare entity teamed up with Talaat Moustafa Group Holding Company (TMG Holding) through a strategic partnership to develop premium-quality medical and healthcare services for an EGP 5 billion hospital in Madinaty.
Gulf Business
09-07-2025
- Business
- Gulf Business
EFG Hermes advises on $190m investment in Alameda Healthcare
Image credit: Suppled photo EFG Hermes, an EFG Holding company and the leading investment bank in the Middle East and North Africa, announced it has acted as the Sole M&A Financial Advisor on a landmark $190m minority stake investment in Alameda Healthcare, one of Egypt's top private healthcare providers. Read- The investment was led by Development Partners International (DPI) in partnership with a consortium of institutional investors and development finance institutions. Following the transaction, Dr Fahad Khater, Chairman of Alameda, will remain the majority shareholder. The deal, primarily structured as a capital increase, is pending regulatory approvals and is expected to close in Q3 2025. This marks the largest foreign direct investment in Egypt's healthcare sector to date, reinforcing investor confidence in Egypt's high-growth, resilient industries. The transaction will inject foreign currency into Egypt's banking system and support Alameda's expansion both locally and in the GCC markets. Strategic expansion supported by capital injection 'This is a proud moment for EFG Hermes as we continue to deliver on our promise to guide clients through transformational transactions,' said Maged El Ayouti, Co-Head of Investment Banking at EFG Hermes. 'Securing a $190m investment for one of the region's fastest-growing healthcare platforms reflects our strong advisory capabilities and deep market expertise.' Alameda, under Dr Khater's leadership, plans to use the proceeds to scale its hospital operations and increase clinical capacity. The funding will support expansion in Egypt, Saudi Arabia, the UAE, and other GCC countries, bolstering its position as a regional healthcare leader. El Ayouti added that the firm's advisory role in this transaction is part of a broader track record of M&A excellence. Over the past 18 months, EFG Hermes has advised on M&A deals worth more than $2.5bn. Since the start of 2025, the investment bank has closed four M&A transactions, along with seven DCM and seven ECM deals across Egypt, the UAE, Saudi Arabia, and Oman. The investment represents a key milestone in both Alameda's growth journey and EFG Hermes's continued dominance in regional capital markets.
Zawya
07-07-2025
- Business
- Zawya
Egypt: EFG Hermes advises on $190mln DPI investment in Alameda
Arab Finance: EFG Hermes, the investment banking arm of EFG Holding, has announced its role as sole M&A financial advisor on a $190 million minority stake investment in Egypt's Alameda Healthcare by Development Partners International (DPI), as per an emailed press release. This was in partnership with a consortium of institutional investors and development finance institutions. The deal, one of the largest foreign direct investments in Egypt's healthcare sector, involves a capital increase and is expected to close in the third quarter (Q3) of 2025, pending regulatory approvals. Fahad Khater will remain the majority shareholder of Alameda following the transaction. The investment is set to boost Alameda's growth across Egypt and the GCC, with proceeds entering the local banking system to support the expansion of hospital operations and clinical capacity in key regional markets. This marks one of several major transactions led by EFG Hermes this year, reinforcing its leadership in M&A, DCM, and ECM advisory across Egypt, the UAE, Saudi Arabia, and Oman. © 2020-2023 Arab Finance For Information Technology. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
07-07-2025
- Business
- Zawya
Development Partners International signs $190mln investment into Alameda
The investment from Development Partners International (DPI) represents the largest ever healthcare investment of its kind in Egypt Alameda Healthcare is Egypt's leading private healthcare group; the new investment will fuel its local and regional expansion, including into the Gulf Cooperation Council (GCC) DPI and its partners will work closely with Alameda Healthcare's leadership team led by Dr. Fahad Khater, Chairman, who remains the majority shareholder London and Cairo – Development Partners International (' DPI '), through funds it advises, and co-investors, have signed a binding agreement for a $190 million minority stake investment in Alameda Healthcare (' Alameda ' or the ' Group '), Egypt's leading private healthcare group (the ' Transaction '). The Transaction, which is primarily a capital increase, is subject to obtaining the relevant regulatory and other approvals and is expected to close in Q3 2025. Marking the largest healthcare investment of its kind in Egypt to date, this new funding will accelerate Alameda's expansion both within the country and across the Gulf Cooperation Council (GCC) region. The proceeds will be used to expand Alameda's footprint and capacity, invest in advanced technologies, and scale the Group's Centers of Excellence. DPI and its partners will collaborate closely with Alameda Healthcare's executive team led by Chairman Dr. Fahad Khater, who retains his position as the majority shareholder, to accelerate the Group's growth and elevate standards of healthcare delivery in Egypt and beyond, leveraging DPI's strategic expertise and operational support. Established in 1999, Alameda Healthcare is Egypt's leading private healthcare group and largest hospital operator with more than 1,000 beds. Alameda Healthcare is renowned for its Centers of Excellence in specialized and sophisticated medical practices, offering high-quality, patient-centric healthcare services. All Alameda hospitals are accredited by the Joint Commission International (JCI), the global gold standard in hospital quality. Out of only five JCI-accredited hospitals in Egypt's private sector, four are part of the Alameda network, making Alameda the only private healthcare group in the country with full JCI accreditation across all its hospitals. Its commitment to clinical excellence, advanced medical technologies, and top-tier patient care has positioned it as one of the most prestigious and trusted healthcare brands in the region. The Group operates a range of services across the healthcare sector. This includes hospitals under two internationally respected tertiary care hospital brands, As-Salam International and Dar Al Fouad; 7 polyclinics across Egypt; a specialized gastroenterology and liver care center, Elixir Gastro and Liver Care Center. The Group also operates a physiotherapy and rehabilitation clinic, German Rehabilitation Center; a home-based family healthcare service provider, Tabibi 24/7 as well as in-house diagnostic centers, medical laboratories, and pharmacies. The Transaction is expected to drive meaningful impact by increasing access to high-quality healthcare. Simultaneously, DPI's investment will support enhanced training and capacity-building for medical professionals, strengthening local talent and helping elevate clinical standards across Egypt's healthcare system. By expanding clinical capacity, introducing advanced technologies, and improving service delivery, Alameda is well positioned to support Egypt's emergence as a regional hub for world-class healthcare. Ziad Abaza, Partner at Development Partners International said: 'This is a milestone transaction for Egypt and for DPI. We're delighted to be supporting Dr. Fahad Khater and his mission of delivering world-class healthcare across Egypt and the GCC. We look forward to working closely with our partners and Alameda's management team to continuing growing our family of hospitals and delivering excellent care to patients.' Dr. Fahad Khater, Chairman of Alameda Healthcare, said: 'Delivering for patients is at the heart of what we do at Alameda and this investment will help us to treat more patients with high quality care. This investment will allow us to expand access to high-quality healthcare across Egypt, especially in underserved areas, while increasing our capacity to serve more patients. It also enables us to invest in training and development, helping to retain and attract top medical talent and reverse the brain drain of Egyptian doctors and nurses. With all our hospitals fully JCI-accredited, this investment further enables us to raise the bar in clinical quality and safety across the region. By enhancing Egypt's position as a destination for medical value travel, we aim to strengthen the country's role as a regional hub for world-class healthcare services. With DPI's specialist regional and healthcare experience we are ideally positioned to launch into our next phase of expansion across the KSA, UAE and other GCC markets.' EFG Hermes acted as the Sole M&A Financial Advisor on the Transaction. Addleshaw Goddard LLP acted as international legal counsel, while ALC Alieldean Weshahi & Partners and Matouk Bassiouny & Hennawy as local legal counsels to Alameda Healthcare. White & Case LLP acted as international and local legal counsel to DPI. PricewaterhouseCoopers (PwC), Debevoise & Plimpton LLP and Rothschild & Co. were also members of DPI's consortium of advisors. About Development Partners International (DPI) DPI is an Africa focused, multi-strategy private investment firm with over US$3 billion in assets under management and co-investments across three funds, targeting high growth, impact-driven, and innovation-led companies. Since DPI was founded in 2007, its ADP funds have completed 33 investments and many exits across Africa. In April 2025, DPI launched DPI Venture Capital, which focuses on unlocking innovation across emerging markets and supporting entrepreneurs on their journey from seed to sale. As a signatory to the UN Principles for Responsible Investment (PRI) and the Operating Principles for Impact Management, DPI promotes high ESG and Impact standards and seeks to contribute to the UN Sustainable Development Goals. DPI Media Contacts Edelman Smithfield Joe Carton, Alfie Tisdall E: DPI@ . About Alameda Healthcare Established in 1999, Alameda Healthcare is Egypt's leading private healthcare group, offering patients access to world-class care and cutting edge treatment options. Through compassionate, personalized medical services delivered across an expanding network of internationally respected hospitals and healthcare institutions, Alameda Healthcare is synonymous with quality care delivered by highly specialized teams of medical professionals who place the patient at the center of everything they do.
Zawya
07-07-2025
- Business
- Zawya
EFG Hermes advises on $190mln investment in Alameda to fuel regional expansion
Egypt - EFG Hermes, an EFG Holding Company, has acted as the sole M&A financial advisor on the signing of binding agreements for a $190 million minority stake investment in Alameda Healthcare by Development Partners International (DPI). Its investment banking division led the transaction in partnership with a consortium of leading institutional investors and prominent development finance institutions, according to a press release. The stake acquisition deal, which mainly involves a capital increase in Alameda, is subject to customary regulatory approvals and is expected to be completed during the third quarter (Q3) of 2025. The capital hike will enable the group to scale its hospital operations and clinical capacity, particularly in Egypt, Saudi Arabia, the UAE, and other GCC markets. Meanwhile, Fahad Khater, Chairman of Alameda, will remain the group's majority shareholder. The agreement, which marks one of the largest foreign direct investments in Egypt's healthcare sector, boosts investor confidence in backing resilient and fast-growing businesses across the country. The foreign currency proceeds will expand Egypt's local banking system and support Alameda's growth in the Arab Republic and the GCC region. Commenting on the transaction, Maged El Ayouti, Co-Head of Investment Banking at EFG Hermes, said: 'This transaction underscores our capabilities to deliver on our advisory to our clients on landmark M&A transactions across Egypt and the broader region, as it follows a series of M&A deals that we have advised on in the last 18 months with an aggregate value exceeding $2.50 billion.' Since the beginning of 2025, EFG Hermes has advised on several transactions in regional markets, including Egypt, Saudi Arabia, the UAE, and Oman. The bargains cover four M&A deals, seven debt capital market (DCM) transactions, and seven equity capital market (ECM) agreements. The company topped equity capital markets in the MENA region during 2024, according to the London Stock Exchange Group (LSEG).
